Article
Phase II Trial of Erlotinib in Elderly Patients with Previously Treated Non-small Cell Lung Cancer: Results of the Lung Oncology Group in Kyushu (LOGiK-0802).
Anticancer research - 1 Jun 2016
Yamada Kazuhiko, Azuma Koichi, Takeshita Masafumi, Uchino Junji, Nishida Chinatsu, Suetsugu Takayuki, Kondo Akira, Harada Taishi, Eida Hirofumi, Kishimoto Junji, Eriguchi Goki, Takayama Koichi, Nakanishi Yoichi, Sugio Kenji
Abstract excerpt
BACKGROUND: As the incidence of lung cancer in the elderly is increasing worldwide, there exists a need to develop a clinically effective, less toxic therapy for this patient population. Although erlotinib has shown proven effectiveness against non-small cell lung cancer (NSCLC), few studies have prospectively investigated its application to elderly patients. PATIENTS AND METHODS: Patients aged ≥75 years with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.